SAN DIEGO--(BUSINESS WIRE)--Sapient, a biomarker discovery organization providing bespoke services for metabolomics and lipidomics data generation and analysis, announced that its high complexity CLIA ...
SAN DIEGO & REHOVOT, Israel--(BUSINESS WIRE)--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced that their San Diego-based clinical ...
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced that its San Diego laboratory has achieved College of American Pathologists (CAP) ...
New wholly owned Lucid subsidiary now performing EsoGuard® Esophageal DNA Test in its own new state-of-the-art CLIA-certified, CAP-accredited clinical laboratory “This critical milestone is the ...
Astrin Biosciences has been awarded accreditation by the College of American Pathologists (CAP) Accreditation Committee following the results of on-site inspection. Recognized for its rigorous and ...
IRVINE, Calif., Jan. 21, 2026 /PRNewswire/ -- Pangea Laboratory, a CLIA-certified, CAP-accredited leader in Next-Generation Sequencing (NGS) and molecular diagnostic validation and innovation, today ...
New York, NY, and Tel Aviv, ISRAEL, Oct. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire--Todos Medical, Ltd. (TOMDF), a comprehensive medical diagnostics and related solutions company, today announced ...
Company sees a significant market opportunity for reference lab agreements to identify which variant is responsible for positive COVID-19 test results Validation paves the way for launch of variant ...
Validation Data on More Than 100 Patients published in Journal of Molecular Diagnostics CHICAGO, April 25, 2025 /PRNewswire/ -- Belay Diagnostics, a CLIA/CAP accredited laboratory focused on the ...
In a cooperative effort to promote the development of personalized medicine based on reverse-phase protein array technology, Aushon BioSystems has placed a 2470 Arrayer in a CAP-CLIA laboratory ...
The successful translation of biomarker discoveries into actionable diagnostic tools requires strict adherence to the robust regulations governing clinical proteomics. As mass spectrometry and ...